RESUMO
A high resolution X-ray diffraction study has been carried out on [(C4H9)4N]2 [V6O13{(OCH2)3CCH2OCCH2CH3}2] (V6-C3) at 100 K. The V6 core possesses a negative charge, leading to a strong polarization of the anion. A nucleophilic region localized near the organic moiety and an electrophilic region in the vicinity of the V6 core provide an overall description of charge-transfer behavior.
RESUMO
The in vitro influence of Keggin structure polyoxotungstates, 12-tungstosilicic acid, H(4)SiW(12)O(40) (WSiA) and 12-tungstophosphoric acid, H(3)PW(12)O(40) (WPA), and monomer Na(2)WO(4) × 2H(2)O on rat synaptic plasma membrane (SPM) Na(+)/K(+)-ATPase and E-NTPDase activity was studied, whereas the commercial porcine cerebral cortex Na(+)/K(+)-ATPase served as a reference. Dose-dependent Na(+)/K(+)-ATPase inhibition was obtained for all investigated compounds. Calculated IC(50) (10 min) values, in mol/l, for SPM/commercial Na(+)/K(+)-ATPase, were: 3.4 × 10(-6)/4.3 × 10(-6), 2.9 × 10(-6)/3.1 × 10(-6) and 1.3 × 10(-3)/1.5 × 10(-3) for WSiA, WPA and Na(2)WO(4) × 2H(2)O, respectively. In the case of E-NTPDase, increasing concentrations of WSiA and WPA induced its activity reduction, while Na(2)WO(4) × 2H(2)O did not noticeably affect the enzyme activity at all investigated concentrations (up to 1 × 10(-3)mol/l). IC(50) (10 min) values, obtained from the inhibition curves, were (in mol/l): 4.1 × 10(-6) for WSiA and 1.6 × 10(-6) for WPA. Monolacunary Keggin anion was found as the main active molecular species present under physiological conditions (in the enzyme assays, pH 7.4), for the both polyoxotungstates solutions (1 mmol/l), using Fourier transform infrared (FT-IR) and micro-Raman spectroscopy. Additionally, commercial porcine cerebral cortex Na(+)/K(+)-ATPase was exposed to the mixture of Na(2)WO(4) × 2H(2)O and WSiA at different concentrations. Additive inhibition effect was achieved for lower concentrations of Na(2)WO(4) × 2H(2)O/WSiA (≤ 1 × 10(-3)/4 × 10(-6) mol/l), while antagonistic effect was obtained for all higher concentrations of the inhibitors.
Assuntos
Apirase/antagonistas & inibidores , Ácidos Fosfóricos/farmacologia , Ácido Silícico/farmacologia , ATPase Trocadora de Sódio-Potássio/antagonistas & inibidores , Membranas Sinápticas/efeitos dos fármacos , Membranas Sinápticas/enzimologia , Compostos de Tungstênio/farmacologia , Animais , Antígenos CD/metabolismo , Apirase/metabolismo , Inibidores Enzimáticos/farmacologia , Masculino , Modelos Moleculares , Ratos , Ratos Wistar , ATPase Trocadora de Sódio-Potássio/metabolismo , Espectroscopia de Infravermelho com Transformada de Fourier , Análise Espectral RamanRESUMO
We have performed X-ray diffraction measurements on single crystals of Na(3)[V(10)O(28)](C(4)N(3)OH(5))(3)(C(4)N(3)OH(6))(3)·10H(2)O as a function of the temperature. When the sample is cooled, from room temperature to 100 K, we have observed additional peaks well indexed in P1, while the phase at room temperature crystallizes in P1. The molecular structure at 210 K indicates that the center of inversion is located between two cytosinium molecules, formally described with a charge of +0.5. When this crystal is heated to room temperature and the structure in P1 reindexed, some peaks remained unindexed. A protonation-deprotonation process gives rise to additional diffraction peaks at temperatures lower than 210 K. The triply bridged hydrogen bonded cytosine-cytosinum dimer is discussed according to the results of the charge density analysis and topological analysis at 210 K. The structure at 100 K has been completely solved based on a comparative study with other compounds containing cytosine-cytosinium dimer. This description could be considered as a reference for such dimer. It could help for discrimination between cytosine and cytosinium molecules, for any new structure containing a cytosine-cytosinium pair, and for which the quality does not allow a precise determination of the hydrogen localization.
Assuntos
Citosina/química , Temperatura , Ânions/química , Cristalização , Dimerização , Difração de Raios XRESUMO
We have synthesized and crystallized a cytosine-decavanadate compound, Na(3) [V(10)O(28)] (C(4)N(3)OH(5))(3)(C(4)N(3)OH(6))(3).10H(2)O, and its crystal structure has been determined from a single-crystal X-ray diffraction. A high resolution X-ray diffraction experiment at 210 K (in P1 space group phase) was carried out. The data were refined using a pseudo-atom multipole model to get the electron density and the electrostatic properties of the decavanadate-cytosine complex. Static deformation density maps and Atoms in Molecules (AIM) topological analysis were used for this purpose. To get insight into the reactivity of the decavanadate anion, we have determined the atomic net charges and the molecular electrostatic potential. Special attention was paid to the hydrogen bonding occurring in the solid state between the decavanadate anion and its environment. The comparison of the experimental electronic characteristics of the decavanadate anions to those found in literature reveals that this anion is a rigid entity conserving its intrinsic properties. This is of particular importance for the future investigations of the biological activities of the decavanadate anion.
Assuntos
Cristalografia por Raios X , Citosina/química , Elétrons , Vanadatos/química , Citosina/síntese química , Ligação de Hidrogênio , Modelos Moleculares , Eletricidade Estática , Vanadatos/síntese químicaRESUMO
The in vitro influence of decameric vanadate species on Na+/K+-ATPase, plasma membrane Ca2+-ATPase (PMCA)-calcium pump and ecto-ATPase activity, using rat synaptic plasma membrane (SPM) as model system was investigated, whereas the commercial porcine cerebral cortex Na+/K+-ATPase served as a reference. The thermal behaviour of the synthesized decavanadate (V10) has been studied by differential scanning calorimetry and thermogravimetric analysis, while the type of polyvanadate anion was identified using the IR spectroscopy. The concentration-dependent responses to V10 of all enzymes were obtained. The half-maximum inhibitory concentration (IC50) of the enzyme activity was achieved at (4.74 +/- 1.15) x 10(-7) mol/l for SPM Na+/K+-ATPase, (1.30 +/- 0.10) x 10(-6) mol/l for commercial Na+/K+-ATPase and (3.13 +/- 1.70) x 10(-8) mol/l for Ca2+-ATPase, while ecto-ATPase is significantly less sensitive toward V10 (IC50 = (1.05 +/- 0.10) x 10(-4) mol/l) than investigated P-type ATPases. Kinetic analysis showed that V10 inhibited Na+/K+-ATPase by reducing the maximum enzymatic velocity and apparent affinity for ATP (increasing K(m) value), implying a mixed mode of interaction between V10 and P-type ATPases.
Assuntos
Adenosina Trifosfatases/química , Membrana Celular/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Sinapses/efeitos dos fármacos , Vanadatos/farmacologia , Adenosina Trifosfatases/antagonistas & inibidores , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/enzimologia , Membrana Celular/química , Membrana Celular/enzimologia , Córtex Cerebral/química , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/enzimologia , Inibidores Enzimáticos/administração & dosagem , Inibidores Enzimáticos/química , Cinética , Masculino , ATPases Transportadoras de Cálcio da Membrana Plasmática/antagonistas & inibidores , ATPases Transportadoras de Cálcio da Membrana Plasmática/química , Ratos , Ratos Wistar , ATPase Trocadora de Sódio-Potássio , Espectrofotometria Infravermelho , Suínos , Sinapses/química , Sinapses/enzimologia , Temperatura , Vanadatos/administração & dosagem , Vanadatos/químicaRESUMO
The influence of three functionalized hexavanadates (V6): Na2 [V6O13{(OCH2)3CCH3}2], [H2]2 [V6O13{(OCH2)3CCH2OCOCH2CH3}2] and [(C4H9)4N]2 [V6O13{(OCH2)3CCH2OOC(CH3)2-COOH}2 on Na+/K+-ATPase activity, was investigated in vitro. Including compounds already tested by Xu et al. (Journal of Inorganic Biochemistry 161 (2016) 27-36), all functionalized hexavanadates inhibit the activity of Na+/K+-ATPase in a dose-dependent manner but with different inhibitory potencies. Na2 [V6O13{(OCH2)3CCH3}2] was found to have the best inhibition properties - showing 50% inhibition IC50â¯=â¯5.50â¯×â¯10-5â¯M, while [(C4H9)4N]2 [V6O13{(OCH2)3CCH2OOC(CH3)2-COOH}2] showed the lowest inhibitory power, IC50â¯=â¯1.31â¯×â¯10-4â¯M. In order to understand the bioactivity of functionalized hexavanadates series, we have also used a combined theoretical approach: determination of electrostatic potential from ab initio theoretical calculations and computation of the molecular interaction field (MIF) surface.
Assuntos
Inibidores Enzimáticos/química , ATPase Trocadora de Sódio-Potássio/antagonistas & inibidores , Vanadatos/química , Animais , Modelos Químicos , Simulação de Acoplamento Molecular , SuínosRESUMO
Influence of 12-tungstophosphoric acid (WPA) on conversion of adenosine triphosphate (ATP) to adenosine diphosphate (ADP) in the presence of Na+/K+-ATPase was monitored by 31P NMR spectroscopy. It was shown that WPA exhibits inhibitory effect on Na+/K+-ATPase activity. In order to study WPA reactivity and intermolecular interactions between WPA oxygen atoms and different proton donor types (D=O, N, C), we have considered data for WPA based compounds from the Cambridge Structural Database (CSD), the Crystallographic Open Database (COD) and the Inorganic Crystal Structure Database (ICSD). Binding properties of Keggin's anion in biological systems are illustrated using Protein Data Bank (PDB). This work constitutes the first determination of theoretical Bader charges on polyoxotungstate compound via the Atom In Molecule theory. An analysis of electrostatic potential maps at the molecular surface and charge of WPA, resulting from DFT calculations, suggests that the preferred protonation site corresponds to WPA bridging oxygen. These results enlightened WPA chemical reactivity and its potential biological applications such as the inhibition of the ATPase activity.
Assuntos
Inibidores Enzimáticos/química , Ácidos Fosfóricos/química , ATPase Trocadora de Sódio-Potássio/antagonistas & inibidores , ATPase Trocadora de Sódio-Potássio/química , Compostos de Tungstênio/química , Animais , Bases de Dados de Proteínas , Humanos , Ressonância Magnética Nuclear BiomolecularRESUMO
In vitro influence of five synthesized functionalized hexavanadates (V6) on commercial porcine cerebral cortex Na(+)/K(+)-ATPase activity has been studied. Dose dependent Na(+)/K(+)-ATPase inhibition was obtained for all investigated compounds. Calculated half maximal inhibitory concentration IC50 values, in mol/L, for Na(+)/K(+)-ATPase were 7.6×10(-5), 1.8×10(-5), 2.9×10(-5), 5.5×10(-5) for functionalized hexavanadates (V6) with tetrabutylammonium (TBA) [V6-CH3][TBA]2, [V6-NO2][TBA]2, [V6-OH][TBA]2 and [V6-C3][TBA]2 respectively. [V6-OH][Na]2 inhibited Na(+)/K(+)-ATPase activity up to 30% at maximal investigated concentration 1×10(-3)mol/L. This reactivity has been interpreted using a study of the non-covalent interactions of functionalized hexavanadate hybrids through Cambridge Structural Database (CSD) analysis. Bibliographic searching has led to 18 different structures and 99 contacts. We have observed that C-Hâ¯O contacts consolidate the structures. We have also performed density functional theory (DFT) calculations and have determined electrostatic potential values at the molecular surface on a series of functionalized V6. These results enlightened their chemical reactivity and their potential biological applications such as the inhibition of the ATPase.